Public Policy

One of the Alliance’s most important missions is to advocate for aging research by working with legislators, health experts and other like-minded organizations. Our public policy efforts are summarized here.

Press Room

Alliance's Bens Offers Testimony on MDUFA before House Committee

Author: Cynthia Bens

Date: March 28th, 2017

Today, the Alliance for Aging Research's Vice President of Public Policy Cynthia Bens testifed before the U.S. House of Representatives' Energy and Commerce Committee, Subcommittee on Health, in regard to reauthorization of the Medical Device User Fee Act (MDUFA).

Publications



Blog

Five Questions (and Answers) about the FDA Reauthorization Act of 2017

Author: Noel Lloyd

Date: July 12th, 2017

Right now, the U.S. Congress is considering the FDA Reauthorization Act of 2017 , legislation that will reauthorize the pharmaceutical, medical device, generic drug, and biosimilar user fee agreements. The five-year deal is one of the most important health care bills Congress will vote on this year.


Alliance's Bens Will Testify on MDUFA and PDUFA Reauthorization

Author: Breanna Bishop

Date: April 3rd, 2017

On April 4, the Alliance for Aging Research’s Vice President of Public Policy Cynthia Bens will testify before the U.S. Senate Committee on Health, Education, Labor and Pensions about the reauthorization of the Prescription Drug User Fee Act and the Medical Device User Fee Act. You can watch the hearing here.


Alliance Comments on the FDA's Commitment Letter for PDUFA VI

Author: Noel Lloyd

Date: August 30th, 2016

In response to a call from the U.S. Food and Drug Administration (FDA) for feedback on its proposed Commitment Letter for the sixth reauthorization of the Prescription Drug User Fee Act (PDUFA), the Alliance for Aging Research submitted comments to the FDA for consideration.


Alliance Offers Comments on FDA OTC Monograph User Fees

Author: Noel Lloyd

Date: June 15th, 2016

Last Friday, on June 10, Vice President of Public Policy Cynthia Bens presented comments on behalf of the Alliance at a U.S. Food and Drug Administration public meeting focused on OTC monograph user fees. 


A December Update on PDUFA and MDUFA

Author: Noel Lloyd

Date: December 22nd, 2015

A December update on PDUFA and MDUFA


PDUFA V Can Help Patients and the FDA

Author: Dan Perry

Date: June 30th, 2011

On June 26, 2011 I was interviewed by BioCentury This Week to share the Alliance for Aging Research’s impressions on the fifth reauthorization of the Food and Drug Administration’s Prescription Drug User Fee program. Thanks to Congress, we and other active patient groups were able to lend an early voice in helping to shape how user fees might be used to help speed the delivery of better treatments and cures to patient in need of relief from Alzheimer’s, Cancer, Parkinson’s and many more diseases.

 

Newsletter

Break Out Your Pantookas and Drums, It is Time to Reauthorize the UFAs

Date: December 13th, 2016

In this edition of Get Mad before You Get Old, Cynthia Bens highlights the importance of swift reauthorization of the FDA user fee programs in the next Congress.

Living Longer & Loving It

Sign up for our electronic newsletter Living Longer & Loving It